282 related articles for article (PubMed ID: 30985551)
1. RETINAL FLECKS IN STARGARDT DISEASE REVEAL CHARACTERISTIC FLUORESCENCE LIFETIME TRANSITION OVER TIME.
Solberg Y; Dysli C; Escher P; Berger L; Wolf S; Zinkernagel MS
Retina; 2019 May; 39(5):879-888. PubMed ID: 30985551
[TBL] [Abstract][Full Text] [Related]
2. Fluorescence Lifetime Imaging in Stargardt Disease: Potential Marker for Disease Progression.
Dysli C; Wolf S; Hatz K; Zinkernagel MS
Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):832-41. PubMed ID: 26934141
[TBL] [Abstract][Full Text] [Related]
3. Autofluorescence Lifetimes in Geographic Atrophy in Patients With Age-Related Macular Degeneration.
Dysli C; Wolf S; Zinkernagel MS
Invest Ophthalmol Vis Sci; 2016 May; 57(6):2479-87. PubMed ID: 27149697
[TBL] [Abstract][Full Text] [Related]
4. Imaging of Hydroxychloroquine Toxicity with Fluorescence Lifetime Imaging Ophthalmoscopy.
Sauer L; Calvo CM; Vitale AS; Henrie N; Milliken CM; Bernstein PS
Ophthalmol Retina; 2019 Oct; 3(10):814-825. PubMed ID: 31345727
[TBL] [Abstract][Full Text] [Related]
5. Fluorescence Lifetime Patterns of Retinal Pigment Epithelium Atrophy in Patients with Stargardt Disease and Age-Related Macular Degeneration.
Solberg Y; Dysli C; Escher P; Berger L; Wolf S; Zinkernagel MS
Ophthalmologica; 2020; 243(3):195-206. PubMed ID: 31743906
[TBL] [Abstract][Full Text] [Related]
6. Fluorescence Lifetimes of Drusen in Age-Related Macular Degeneration.
Dysli C; Fink R; Wolf S; Zinkernagel MS
Invest Ophthalmol Vis Sci; 2017 Sep; 58(11):4856-4862. PubMed ID: 28973332
[TBL] [Abstract][Full Text] [Related]
7. FUNDUS AUTOFLUORESCENCE LIFETIMES AND CENTRAL SEROUS CHORIORETINOPATHY.
Dysli C; Berger L; Wolf S; Zinkernagel MS
Retina; 2017 Nov; 37(11):2151-2161. PubMed ID: 28099314
[TBL] [Abstract][Full Text] [Related]
8. FLUORESCENCE LIFETIME PATTERNS IN MACULAR TELANGIECTASIA TYPE 2.
Solberg Y; Dysli C; Wolf S; Zinkernagel MS
Retina; 2020 Jan; 40(1):99-108. PubMed ID: 30664123
[TBL] [Abstract][Full Text] [Related]
9. LONGITUDINAL FLUORESCENCE LIFETIME IMAGING OPHTHALMOSCOPY ANALYSIS IN PATIENTS WITH MACULAR TELANGIECTASIA TYPE 2 (MacTel).
Sauer L; Vitale AS; Modersitzki NK; Bernstein PS
Retina; 2021 Jul; 41(7):1416-1427. PubMed ID: 34137386
[TBL] [Abstract][Full Text] [Related]
10. Monitoring foveal sparing in geographic atrophy with fluorescence lifetime imaging ophthalmoscopy - a novel approach.
Sauer L; Klemm M; Peters S; Schweitzer D; Schmidt J; Kreilkamp L; Ramm L; Meller D; Hammer M
Acta Ophthalmol; 2018 May; 96(3):257-266. PubMed ID: 29105362
[TBL] [Abstract][Full Text] [Related]
11. Flecks in Recessive Stargardt Disease: Short-Wavelength Autofluorescence, Near-Infrared Autofluorescence, and Optical Coherence Tomography.
Sparrow JR; Marsiglia M; Allikmets R; Tsang S; Lee W; Duncker T; Zernant J
Invest Ophthalmol Vis Sci; 2015 Jul; 56(8):5029-39. PubMed ID: 26230768
[TBL] [Abstract][Full Text] [Related]
12. Progressive Dysmorphia of Retinal Pigment Epithelium in Age-Related Macular Degeneration Investigated by Fluorescence Lifetime Imaging.
Hammer M; Jakob-Girbig J; Schwanengel L; Curcio CA; Hasan S; Meller D; Schultz R
Invest Ophthalmol Vis Sci; 2021 Sep; 62(12):2. PubMed ID: 34491262
[TBL] [Abstract][Full Text] [Related]
13. Effect of pharmacologically induced retinal degeneration on retinal autofluorescence lifetimes in mice.
Dysli C; Dysli M; Zinkernagel MS; Enzmann V
Exp Eye Res; 2016 Dec; 153():178-185. PubMed ID: 27777124
[TBL] [Abstract][Full Text] [Related]
14. Quantitative analysis of fluorescence lifetime measurements of the macula using the fluorescence lifetime imaging ophthalmoscope in healthy subjects.
Dysli C; Quellec G; Abegg M; Menke MN; Wolf-Schnurrbusch U; Kowal J; Blatz J; La Schiazza O; Leichtle AB; Wolf S; Zinkernagel MS
Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2106-13. PubMed ID: 24569585
[TBL] [Abstract][Full Text] [Related]
15. Fundus Autofluorescence Lifetime Patterns in Retinitis Pigmentosa.
Dysli C; Schuerch K; Escher P; Wolf S; Zinkernagel MS
Invest Ophthalmol Vis Sci; 2018 Apr; 59(5):1769-1778. PubMed ID: 29610860
[TBL] [Abstract][Full Text] [Related]
16. LONGITUDINAL FOVEAL FLUORESCENCE LIFETIME CHARACTERISTICS IN GEOGRAPHIC ATROPHY USING FLUORESCENCE LIFETIME IMAGING OPHTHALMOSCOPY.
Lincke JB; Dysli C; Jaggi D; Solberg Y; Wolf S; Zinkernagel MS
Retina; 2021 Nov; 41(11):2391-2398. PubMed ID: 34282069
[TBL] [Abstract][Full Text] [Related]
17. Characterization of stargardt disease using polarization-sensitive optical coherence tomography and fundus autofluorescence imaging.
Ritter M; Zotter S; Schmidt WM; Bittner RE; Deak GG; Pircher M; Sacu S; Hitzenberger CK; Schmidt-Erfurth UM;
Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6416-25. PubMed ID: 23882696
[TBL] [Abstract][Full Text] [Related]
18. Autofluorescence Lifetimes in Patients With Choroideremia Identify Photoreceptors in Areas With Retinal Pigment Epithelium Atrophy.
Dysli C; Wolf S; Tran HV; Zinkernagel MS
Invest Ophthalmol Vis Sci; 2016 Dec; 57(15):6714-6721. PubMed ID: 27951593
[TBL] [Abstract][Full Text] [Related]
19. Fluorescence lifetime imaging ophthalmoscopy: autofluorescence imaging and beyond.
Sauer L; Vitale AS; Modersitzki NK; Bernstein PS
Eye (Lond); 2021 Jan; 35(1):93-109. PubMed ID: 33268846
[TBL] [Abstract][Full Text] [Related]
20. Insights into autofluorescence patterns in Stargardt macular dystrophy using ultra-wide-field imaging.
Kumar V
Graefes Arch Clin Exp Ophthalmol; 2017 Oct; 255(10):1917-1922. PubMed ID: 28689222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
